Eledon Pharmaceuticals, Inc.ELDNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Accelerating
Trending higher, slight contraction.
Left:
||||
Year-over-year research & development expense growth
Latest
71.43%
↑ 14% above average
Average (9y)
62.50%
Historical baseline
Range
High:287.13%
Low:-91.92%
CAGR
-5.9%
Structural decline
| Period | Value |
|---|---|
| 2024 | 71.43% |
| 2023 | 11.94% |
| 2022 | 14.09% |
| 2021 | 287.13% |
| 2020 | -24.57% |
| 2019 | 19.23% |
| 2018 | 237.14% |
| 2017 | -91.92% |
| 2016 | -23.33% |
| 2015 | 123.90% |